Nuvo Pharmaceuticals Inc (MRV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,589 | 48,680 | 48,275 | 12,668 | 12,261 |
| Marketable Securities | 8,000 | N/A | 10,000 | N/A | N/A |
| Receivables | 2,615 | 6,001 | 3,005 | 4,485 | 4,019 |
| Inventories | 3,817 | 2,402 | 1,929 | 990 | 1,156 |
| Other current assets | 995 | 728 | 770 | 0 | 0 |
| TOTAL | $25,292 | $57,952 | $63,979 | $18,341 | $18,132 |
| Non-Current Assets | |||||
| PPE Net | 1,224 | 1,180 | 1,161 | 1,411 | 1,614 |
| Intangibles | N/A | N/A | 0 | 1,869 | 8,739 |
| TOTAL | $1,224 | $1,180 | $1,161 | $3,280 | $10,353 |
| Total Assets | $26,516 | $59,132 | $65,140 | $21,621 | $28,485 |
| Liabilities | |||||
| Current Liabilities | |||||
| Other current liabilities | 2 | 192 | 140 | N/A | N/A |
| TOTAL | $3,648 | $9,370 | $9,289 | $6,096 | $5,601 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 0 | 57 | 341 |
| Other Non-Current Liabilities | 7 | 43 | 188 | 0 | 0 |
| TOTAL | $7 | $43 | $188 | $3,327 | $1,415 |
| Total Liabilities | $3,655 | $9,413 | $9,477 | $9,423 | $7,016 |
| Shareholders' Equity | |||||
| Retained earnings | -176,458 | -200,059 | -192,939 | -231,529 | -221,151 |
| Other shareholders' equity | 2 | 1,059 | 1,124 | 1,086 | 420 |
| TOTAL | $22,861 | $49,719 | $55,663 | $12,198 | $21,469 |
| Total Liabilities And Equity | $26,516 | $59,132 | $65,140 | $21,621 | $28,485 |